The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index < 35 kg/m(2): preliminary results
- PMID: 25844356
- PMCID: PMC4384281
- DOI: 10.4174/astr.2015.88.4.215
The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index < 35 kg/m(2): preliminary results
Abstract
Purpose: We applied a long Roux-en-Y (RY) gastrojejunostomy (bypassed jejunum over 100 cm) as a reconstruction method for diabetes control to gastric cancer patients with type 2 diabetes and body mass index (BMI) < 35 kg/m(2). The effect of this procedure on diabetes control was assessed.
Methods: We prospectively performed modified RY gastrojejunostmy after curative radical distal gastrectomy. Thirty patients had completed a 1-year follow-up. Patients were followed concerning their diabetic status. The factors included in the investigation were length of bypassed jejunum, BMI and its reduction ratio, glycated hemoglobin (HbA1c), fasting blood glucose, and duration of diabetes. Diabetic status after surgery was assessed in three categories: remission, improvement, and stationary. In evaluation of surgical effects on diabetes control, remission and improvement groups were regarded as effective groups, while stationary was regarded as an ineffective group.
Results: At postoperative one year, statistical significance was observed in the mean BMI and HbA1c. Diabetes control was achieved in 50% of the patients (remission, 30%; improvement, 20%). BMI reduction ratio, preoperative HbA1c, and duration of diabetes were correlated to the status of type 2 diabetes mellitus. The preoperative HbA1c was the most influential predictor in diabetic control.
Conclusion: The effect of long RY gastrojejunostomy after gastrectomy for diabetes control could be contentious but an applicable reconstruction method for diabetes control in gastric cancer patients with type 2 diabetes and BMI < 35 kg/m(2). Diabetes remission is expected to be higher in patients with greater BMI reduction, short duration of diabetes, and lower preoperative HbA1c.
Keywords: Bariatric surgery; Roux-en-Y anastomosis; Stomach neoplasms; Type 2 diabetes mellitus.
Conflict of interest statement
Figures
Similar articles
-
Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1061-8. doi: 10.1016/j.soard.2014.12.029. Epub 2015 Jan 5. Surg Obes Relat Dis. 2015. PMID: 25843397 Clinical Trial.
-
A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients.PLoS One. 2017 Dec 7;12(12):e0188904. doi: 10.1371/journal.pone.0188904. eCollection 2017. PLoS One. 2017. PMID: 29216250 Free PMC article. Clinical Trial.
-
Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.Obes Surg. 2016 Oct;26(10):2291-301. doi: 10.1007/s11695-016-2118-z. Obes Surg. 2016. PMID: 26935711
-
Resolution of type 2 diabetes after gastrectomy for gastric cancer with long limb Roux-en Y reconstruction: a prospective pilot study.J Korean Surg Soc. 2013 Feb;84(2):88-93. doi: 10.4174/jkss.2013.84.2.88. Epub 2013 Jan 29. J Korean Surg Soc. 2013. PMID: 23396643 Free PMC article.
-
Radical Gastrectomy Combined with Modified Gastric Bypass Surgery for Gastric Cancer Patients with Type 2 Diabetes.Cell Biochem Biophys. 2015 Jul;72(3):839-44. doi: 10.1007/s12013-015-0546-3. Cell Biochem Biophys. 2015. PMID: 25677989
Cited by
-
Metabolic Surgery in Korea: What to Consider before Surgery.Endocrinol Metab (Seoul). 2017 Sep;32(3):307-315. doi: 10.3803/EnM.2017.32.3.307. Endocrinol Metab (Seoul). 2017. PMID: 28956359 Free PMC article. Review.
-
Prediction of antidiabetic effect after gastrectomy with Roux-en-Y reconstruction in patients with gastric cancer and type 2 diabetes.Medicine (Baltimore). 2022 Sep 9;101(36):e30309. doi: 10.1097/MD.0000000000030309. Medicine (Baltimore). 2022. PMID: 36086777 Free PMC article.
-
Current Status and Trends of Minimally Invasive Gastrectomy in Korea.Medicina (Kaunas). 2021 Nov 3;57(11):1195. doi: 10.3390/medicina57111195. Medicina (Kaunas). 2021. PMID: 34833413 Free PMC article. Review.
-
Oncometabolic surgery: Emergence and legitimacy for investigation.Chin J Cancer Res. 2020 Apr;32(2):252-262. doi: 10.21147/j.issn.1000-9604.2020.02.12. Chin J Cancer Res. 2020. PMID: 32410802 Free PMC article.
-
Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.Clin Transl Oncol. 2017 Jun;19(6):682-694. doi: 10.1007/s12094-016-1601-2. Epub 2017 Jan 10. Clin Transl Oncol. 2017. PMID: 28074400
References
-
- Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–1585. - PubMed
-
- Shukla AP, Ahn SM, Patel RT, Rosenbaum MW, Rubino F. Surgical treatment of type 2 diabetes: the surgeon perspective. Endocrine. 2011;40:151–161. - PubMed
-
- Dixon JB, Zimmet P, Alberti KG, Rubino F International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Arq Bras Endocrinol Metabol. 2011;55:367–382. - PubMed
-
- Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737. - PubMed
-
- Chiellini C, Rubino F, Castagneto M, Nanni G, Mingrone G. The effect of biliopancreatic diversion on type 2 diabetes i n pat ients wit h BMI <35 kg/m2. Diabetologia. 2009;52:1027–1030. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials